An Antibody-Drug Conjugate Designed Through Clone and Isotype Selection Restricts the Growth of CSPG4-Expressing Triple-Negative Breast Cancer

An Antibody-Drug Conjugate Designed Through Clone and Isotype Selection Restricts the Growth of CSPG4-Expressing Triple-Negative Breast Cancer

Esapa, B., Liu, Y., Chenoweth, A., Stoker, K., Łabędź, N., Romero Clavijo, P., Ilieva, K., Trendell, J., Navarro-Llinas, B., Suriawinata, E., Butcher, T., Wang, N., Grandits, M., Gusmao Ferreira, L. C., McCraw, A., Crescioli, S., Johansson, A., Irshad, S., Grigoriadis, A. & Gazinska, P. & 7 others, Tsoka, S., Chudasama, V., Baker, J. R., Tutt, A., Cheung, A., Karagiannis, S. N. & Thurston, D., 16 Feb 2026, (Accepted/In press) In: NPJ precision oncology.

Research output: Contribution to journal › Article › peer-review